At a glance
ClinicalIndex Comparison RecordN/ACompleted· 270 enrolled
Drug / intervention
GAL1704 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
In Brief
A clinical study evaluating GAL1704 and Juvederm Voluma for Cheek Augmentation. Completed, enrolled 270 participants across 15 sites.
Detailed Summary
An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCheek Augmentation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartOct 2018
Primary CompletionJun 2019
Study CompletionMay 2020
TodayJul 2026
First PostedOct 9, 2018
Enrollment StartOct 18, 2018
Primary CompletionJun 10, 2019
Study CompletionMay 22, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.7 years ago
Interventions
GAL1704device
new dermal filler
Juvederm Volumadevice
hyaluronic acid